Science
Mechanism of Action
Operates through a quaternary pathway: it stimulates TIMP3 expression to suppress VEGF-induced angiogenesis (reducing visible redness), upregulates Fibroblast Growth Factors (FGF) to accelerate collagen synthesis, utilizes carotenoids like violaxanthin for DNA protection against UV damage, and deploys high-molecular-weight polysaccharides to lock in moisture via humectancy.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 A 1.0% concentration applied twice daily for 84 days demonstrated a 77% reduction in telangiectasia (redness) and a significant decrease in the appearance of spider veins.
- 02 In vitro analysis at 0.1% showed a 46% reduction in blood vessel length, confirming its efficacy in managing rosacea-prone skin.
- 03 Higher concentrations (up to 15.0%) have been shown to drastically accelerate wound healing by stimulating fibroblast proliferation.
Transparency
Dusting Analysis
While 0.1% provides basic antioxidant protection, the clinically validated reduction in redness and vascular lesions requires a 1.0% threshold. Formulas listing this ingredient near the bottom of the INCI list often fail to deliver its specific anti-angiogenic benefits.
The Formula
Formulation
Stability
Thermolabile; exposure to temperatures exceeding 60°C degrades essential pigments and bioactivity. Must be incorporated during the cool-down phase.
Synergies
- Vitamin C (antioxidant reinforcement)
- Niacinamide (barrier synergy)
- Peptides (collagen stimulation)
Conflicts
- Strong oxidizing agents
- High electrolyte concentrations (may destabilize polymer-based delivery systems)
Safety
Safety Profile
Classified as GRAS (Generally Recognized as Safe) in food; maintains a low hazard score of 1 on EWG.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An exceptional bioactive for treating chronic redness and vascular fatigue when formulated at a minimum 1.0% concentration.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources